Loading
BT
Briapro Therapeutics Corp. Stock: price and insider trades · Canada
Briapro Therapeutics Corp.: what insiders have been doing
Briapro Therapeutics Corp. is a listed company. Filings by its managers are published through SEDI. Between 18 October 2025 and 18 October 2026, 5 insiders published 15 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
For context, the typical company on the same exchange (median of 2,134 companies) published 12 filings over the same period, against 15 filings here.
Insider buying of Briapro Therapeutics Corp. has been absent for the past year.
This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Insider Decl.
15
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Financial data
· cache
Last declaration on 24 September 2026
Declarations15 total
2,157,000 sharesRestricted Stock UnitsTSXSEDI:4781112
Restricted Stock UnitsTSXSEDI:4781111
719,000 sharesRestricted Stock UnitsTSXSEDI:4781103
Restricted Stock UnitsTSXSEDI:4781100
1,438,000 sharesRestricted Stock UnitsTSXSEDI:4780851
Restricted Stock UnitsTSXSEDI:4780850
359,000 sharesRestricted Stock UnitsTSXSEDI:4780849
Restricted Stock UnitsTSXSEDI:4780846
359,000 sharesRestricted Stock UnitsTSXSEDI:4780828
Restricted Stock UnitsTSXSEDI:4780822
359,000 sharesCommon SharesTSXSEDI:4701078
359,000 sharesCommon SharesTSXSEDI:4701070
719,000 sharesCommon SharesTSXSEDI:4701061
1,438,000 sharesCommon SharesTSXSEDI:4701047
2,157,000 sharesCommon SharesTSXSEDI:4701029
15 of 15 declarations
About Briapro Therapeutics Corp.
Briapro Therapeutics Corp. is a company listed on the XTSE market, focused on developing innovative therapeutic treatments. It concentrates on research and development of solutions for specific diseases.
